Skip to content

Development and clinical application of single-port thoracoscopic minimally invasive surgical instruments

Development and clinical application of single-port thoracoscopic minimally invasive surgical instruments

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037183
Enrollment
Unknown
Registered
2020-08-27
Start date
2021-10-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

New equipment group:surgery using new single-port endoscope instrument
normal equipment group:Surgery using traditional single port endoscopic instruments

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: a. 18-80 years old, no gender limit; b. Those who have no previous history of other cancers; c. Patients who meet the conditions of endoscopic surgery.

Exclusion criteria

Exclusion criteria: a. Intraoperative bleeding cannot be controlled and turned to thoracotomy; b. Intraoperative lymph node resection is difficult to switch to multi-hole endoscopy and thoracotomy.

Design outcomes

Primary

MeasureTime frame
survival time;operative time;blood loss in operation;

Countries

China

Contacts

Public ContactXiaogang Zhao

Shanghai Pulmonary Hospital

xiaobenben20000cn@163.com+86 18616587602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026